cannabis Related Content

Canna CBD Limited chart the impact of cannabidiol on mainstream fast-moving consumer goods, adopting custom from other lifestyle categories, such as alcohol, tobacco/vaping, cosmetics and health foods.

Ian C Tordoff, CEO of Block Commodities Ltd, provides a snap-shot of changes in the medical marijuana industry.

Henri Sant-Cassia from CBD Virtue turns the spotlight onto industrial hemp, a part of the cannabis sativa family.

AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.

Lorenza Romanese, Managing Director of the European Industrial Hemp Association (EIHA) examines the future of hemp and explains in this vein, what is at stake, as well as looking back at its fascinating history.

Cannabis patient, budtender and growers assistant, Caleb McMillan, ponders if there is a difference between Sativa and Indica cannabis.

As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.

A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.

Simon Manthorpe, CEO of EOS Scientific, explains why CBD oil could be the answer for a calming solution to Seasonal Affective Disorder.

The Elixinol Group operates in the industrial hemp and medicinal cannabis industries, offering the highest quality and potency CBD products on the market.

Is the cannabis industry in the UK a risky business? John Binns, Partner at BCL Solicitors LLP finds out more.

Mile High Labs International Limited provides a brief introduction to a brand-new industry, CBD, a non-psychoactive cannabinoid.

Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.

GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.

In the first of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the medicinal use of cannabis derivatives.

Whether you see it as the “latest” health craze, have considered taking it yourself, or, have been relying on it for some time now, you may have asked: Can someone take too much CBD? Here, we find out.

Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.

Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.

CBDepot, a pioneer in the production of high-quality natural cannabinoid ingredients and a world-leading researcher highlights the work they conduct here.

Sophia Ali co-founder of Amma Life shares her views on supporting your mental health through the use of CBD oil and other methods, here.